Research Review and Update: IQUIX (Levofloxacin 1.5%)
Author:
- 1 January 2006
- journal article
- review article
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 46 (4) , 47-60
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Safety and efficacy of levofloxacin 1.5% eyedrops in nonhuman primates having penetrating keratoplastyJournal of Cataract & Refractive Surgery, 2005
- Corneal penetration of fluoroquinolones: Aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedropsJournal of Cataract & Refractive Surgery, 2005
- Comprehensive Evaluation of Ocular Toxicity of Topical Levofloxacin in Rabbit and Primate ModelsJournal of Toxicology- Cutaneous and Ocular Toxicology, 2004
- Aqueous Penetration of Gatifloxacin and Levofloxacin into the Rabbit Aqueous Humor Following Topical DosingJournal of Ocular Pharmacology and Therapeutics, 2004
- An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsificationAmerican Journal of Ophthalmology, 2004
- Emerging ciprofloxacin-resistant Pseudomonas aeruginosaAmerican Journal of Ophthalmology, 1999
- Emerging fluoroquinolone resistance in bacterial keratitisOphthalmology, 1999
- Aqueous solubilities of some variously substituted quinolone antimicrobialsInternational Journal of Pharmaceutics, 1990